prednisone has been researched along with Chronic Hepatitis B in 30 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We evaluated the safety and efficacy of lamivudine and interferon alfa-2b with prior immunosuppression with prednisone in patients with HBeAg-positive chronic hepatitis B (CHB)." | 9.12 | [Sequential combination therapy with prednisone, lamivudine and interferon alfa-2b for HBeAg-positive chronic hepatitis B]. ( Arús Soler, E; Dávila González, Y; Grá Oramas, B; Ruenes Domech, C; Vilar Gómez, E, 2006) |
| "This prospective study aimed to investigate the efficacy and safety of preemptive antiviral therapy with tenofovir disoproxil fumarate (TDF) for HBsAg-positive patients with newly diagnosed diffuse large B-cell lymphoma receiving rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) chemotherapy." | 8.31 | A Prospective Study of Preemptive Tenofovir Disoproxil Fumarate Therapy in HBsAg-Positive Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone. ( Chang, MH; Eom, HS; Hyun, SY; Jo, JC; Kang, HJ; Kim, DY; Kim, HJ; Kim, IH; Kim, JS; Kim, MK; Kim, WS; Kim, YR; Kwak, JY; Lee, JO; Lee, WS; Lim, SN; Mun, YC; Park, Y; Shin, HJ; Suh, C; Yang, DH; Yoo, KH; Yoon, DH, 2023) |
| " We evaluated the safety and efficacy of lamivudine and interferon alfa-2b with prior immunosuppression with prednisone in patients with HBeAg-positive chronic hepatitis B (CHB)." | 5.12 | [Sequential combination therapy with prednisone, lamivudine and interferon alfa-2b for HBeAg-positive chronic hepatitis B]. ( Arús Soler, E; Dávila González, Y; Grá Oramas, B; Ruenes Domech, C; Vilar Gómez, E, 2006) |
| "Twelve patients with a history of childhood malignancy and chronic hepatitis B were treated with prednisone for 4 weeks (0." | 5.10 | Serological and molecular response on combined antiviral treatment in children with chronic hepatitis B after pediatric malignancy. ( Benesch, M; Deutsch, J; Dornbusch, HJ; Kerbl, R; Kessler, HH; Lackner, H; Moser, A; Schwinger, W; Sovinz, P; Urban, C, 2002) |
| "This prospective study aimed to investigate the efficacy and safety of preemptive antiviral therapy with tenofovir disoproxil fumarate (TDF) for HBsAg-positive patients with newly diagnosed diffuse large B-cell lymphoma receiving rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) chemotherapy." | 4.31 | A Prospective Study of Preemptive Tenofovir Disoproxil Fumarate Therapy in HBsAg-Positive Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone. ( Chang, MH; Eom, HS; Hyun, SY; Jo, JC; Kang, HJ; Kim, DY; Kim, HJ; Kim, IH; Kim, JS; Kim, MK; Kim, WS; Kim, YR; Kwak, JY; Lee, JO; Lee, WS; Lim, SN; Mun, YC; Park, Y; Shin, HJ; Suh, C; Yang, DH; Yoo, KH; Yoon, DH, 2023) |
| "We prospectively enrolled patients with negative hepatitis B surface antigen positive Anti-hepatitis B core status with or without corticosteroid use and determined corticosteroid exposure by calculating cumulative dose and time-weighted average daily dose of prednisone." | 4.12 | Average corticosteroid dose and risk for HBV reactivation and hepatitis flare in patients with resolved hepatitis B infection. ( Dai, L; Feng, X; Gao, Y; Liao, W; Su, G; Wu, Q; Yang, P; Zhong, Z, 2022) |
| " We aimed to explore the effectiveness and safety of low-dose prednisone or cyclosporine A (CsA) combined with nucleoside analog (NA) in patients with severe thrombocytopenia associated with HBV-related LC." | 2.80 | Immunosuppressive treatment combined with nucleoside analog is superior to nucleoside analog only in the treatment of severe thrombocytopenia in patients with cirrhosis associated with hepatitis B in China: A multicenter, observational study. ( Feng, R; Fu, HX; Hu, JD; Huang, XJ; Jiang, H; Jiang, M; Jiang, Q; Liu, H; Ma, H; Niu, T; Wang, H; Wang, JW; Wang, X; Wang, Z; Wei, L; Xie, YD; Xu, LP; Zhang, XH; Zhu, XL, 2015) |
| "5-3 times the upper limit of normal received prednisone for a total of six weeks prior to interferon starting at 60 mg daily with reduction in dosage by 20 mg every two weeks with a two-week period between finishing prednisone and starting interferon-alpha2b." | 2.69 | Interferon-alpha2b therapy is efficacious in Asian-Americans with chronic hepatitis B infection: a prospective controlled trial. ( Hann, HW; Maddrey, WC; Martin, P; Muñoz, SJ; Rubin, R; Westerberg, S, 1998) |
| "Immunoglobulin G4 (IgG4)-associated autoimmune hepatitis (AIH) was recognized as a new disease entity; however, IgG4-associated de novo AIH after the liver transplantation had not been reported yet." | 2.49 | Immunoglobulin G4-associated de novo autoimmune hepatitis after liver transplantation for chronic hepatitis B- and C-related cirrhosis and hepatocellular carcinoma: a case report with literature review. ( Jia, JD; Rakhda, MI; Wang, TI; Zhao, XY, 2013) |
| "Among these optic neuritis is a rare presentation with only a handful of cases reported in the literature thus far." | 1.48 | Recurrent optic neuritis as the only manifestation of chronic hepatitis B virus flare: a case report. ( Asif, A; Campbell, N; Curras-Martin, D; Haroon, A; Hossain, MA, 2018) |
| "We report a case of autoimmune thrombocytopenia associated with acute reverse seroconversion of hepatitis B in a patient who was initially hepatitis B virus surface antigen negative and hepatitis B virus surface antibody positive." | 1.36 | Exacerbation of chronic idiopathic thrombocytopenic purpura following reactivation of an occult hepatitis B. ( Allegra, A; Alonci, A; D'Angelo, A; Granata, A; Musolino, C; Penna, G, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (6.67) | 18.2507 |
| 2000's | 11 (36.67) | 29.6817 |
| 2010's | 14 (46.67) | 24.3611 |
| 2020's | 3 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhong, Z | 1 |
| Liao, W | 1 |
| Dai, L | 1 |
| Feng, X | 1 |
| Su, G | 1 |
| Gao, Y | 1 |
| Wu, Q | 1 |
| Yang, P | 1 |
| Kim, DY | 1 |
| Kim, YR | 1 |
| Suh, C | 1 |
| Yoon, DH | 1 |
| Yang, DH | 1 |
| Park, Y | 1 |
| Eom, HS | 1 |
| Lee, JO | 2 |
| Kwak, JY | 1 |
| Kang, HJ | 1 |
| Hyun, SY | 1 |
| Jo, JC | 1 |
| Chang, MH | 1 |
| Yoo, KH | 1 |
| Lim, SN | 1 |
| Shin, HJ | 1 |
| Kim, WS | 1 |
| Kim, IH | 1 |
| Kim, MK | 1 |
| Kim, HJ | 1 |
| Lee, WS | 1 |
| Mun, YC | 1 |
| Kim, JS | 1 |
| Park, J | 1 |
| Chung, SW | 1 |
| Lee, YB | 1 |
| Shin, H | 1 |
| Hur, MH | 1 |
| Cho, H | 1 |
| Park, MK | 1 |
| Youk, J | 1 |
| Lee, JY | 1 |
| Yu, SJ | 1 |
| Kim, YJ | 1 |
| Yoon, JH | 1 |
| Kim, TM | 1 |
| Lee, JH | 2 |
| Curras-Martin, D | 1 |
| Campbell, N | 1 |
| Haroon, A | 1 |
| Hossain, MA | 1 |
| Asif, A | 1 |
| Zhao, XY | 1 |
| Rakhda, MI | 1 |
| Wang, TI | 1 |
| Jia, JD | 1 |
| Xuan, D | 1 |
| Yu, Y | 1 |
| Shao, L | 1 |
| Wang, J | 1 |
| Zhang, W | 1 |
| Zou, H | 1 |
| Garcias-Ladaria, J | 1 |
| Pérez-Ferriols, A | 2 |
| Ortega-García, P | 1 |
| Diago, M | 1 |
| Shafran, DM | 1 |
| Bunce, PE | 1 |
| Gold, WL | 1 |
| Zhang, XH | 1 |
| Feng, R | 1 |
| Xu, LP | 1 |
| Jiang, Q | 1 |
| Jiang, H | 1 |
| Fu, HX | 1 |
| Liu, H | 1 |
| Niu, T | 1 |
| Wang, X | 1 |
| Hu, JD | 1 |
| Jiang, M | 1 |
| Wang, Z | 1 |
| Wang, JW | 1 |
| Ma, H | 1 |
| Xie, YD | 1 |
| Zhu, XL | 1 |
| Wang, H | 1 |
| Wei, L | 1 |
| Huang, XJ | 1 |
| Ha, JM | 1 |
| Sohn, W | 1 |
| Cho, JY | 1 |
| Pyo, JH | 1 |
| Choi, K | 1 |
| Sinn, DH | 1 |
| Gwak, GY | 1 |
| Choi, MS | 1 |
| Koh, KC | 1 |
| Paik, SW | 1 |
| Yoo, BC | 1 |
| Paik, YH | 1 |
| Wei, DW | 1 |
| Pagnoux, C | 1 |
| Chan, CC | 1 |
| Chicharro, P | 1 |
| Rodríguez-Jiménez, P | 1 |
| de Argila, D | 1 |
| Dillon, R | 1 |
| Hirschfield, GM | 1 |
| Allison, ME | 1 |
| Rege, KP | 1 |
| Zaragoza, V | 1 |
| Martínez, L | 1 |
| Alegre, V | 1 |
| Zeitz, J | 1 |
| Mullhaupt, B | 1 |
| Fruehauf, H | 1 |
| Rogler, G | 1 |
| Vavricka, SR | 1 |
| Allegra, A | 1 |
| Penna, G | 1 |
| Alonci, A | 1 |
| Granata, A | 1 |
| D'Angelo, A | 1 |
| Musolino, C | 1 |
| Muñoz Bertrán, E | 1 |
| Pérez Ceballos, E | 1 |
| Gómez Espín, R | 1 |
| Ortega González, I | 1 |
| Coppola, N | 1 |
| Masiello, A | 1 |
| Tonziello, G | 1 |
| Macera, M | 1 |
| Iodice, V | 1 |
| Caprio, N | 1 |
| Pasquale, G | 1 |
| Iavarone, M | 1 |
| Perrino, M | 1 |
| Viganò, M | 1 |
| Beck-Peccoz, P | 1 |
| Fugazzola, L | 1 |
| Wijaya, I | 1 |
| Sanityoso, A | 1 |
| Lesmana, LA | 1 |
| Lackner, H | 1 |
| Moser, A | 1 |
| Benesch, M | 1 |
| Deutsch, J | 1 |
| Kessler, HH | 1 |
| Kerbl, R | 1 |
| Schwinger, W | 1 |
| Dornbusch, HJ | 1 |
| Sovinz, P | 1 |
| Urban, C | 1 |
| Heathcote, J | 1 |
| Vilar Gómez, E | 1 |
| Grá Oramas, B | 1 |
| Arús Soler, E | 1 |
| Ruenes Domech, C | 1 |
| Dávila González, Y | 1 |
| Fernández Fernández, FJ | 1 |
| de la Fuente Aguado, J | 1 |
| Puerta Louro, R | 1 |
| Fernández Villaverde, A | 1 |
| Soto Ríos, C | 1 |
| Martin, P | 1 |
| Hann, HW | 1 |
| Westerberg, S | 1 |
| Muñoz, SJ | 1 |
| Rubin, R | 1 |
| Maddrey, WC | 1 |
| Henrion, J | 1 |
| Charton-Bain, MC | 1 |
| Lelong, B | 1 |
| Bouabdallah, R | 1 |
| Dubus, P | 1 |
| Merlio, JP | 1 |
| Hassoun, J | 1 |
| Xerri, L | 1 |
| Suárez García, E | 1 |
| Romero Gómez, M | 1 |
| Grande Santamaría, L | 1 |
| Matano, S | 1 |
| Kobayashi, K | 1 |
| Ohta, H | 1 |
| Minouchi, K | 1 |
| Sanada, T | 1 |
| Sugimoto, T | 1 |
| Tupasi, TE | 1 |
| Co, VM | 1 |
| Clarin, MS | 1 |
| Alesna, ET | 1 |
| Divinagracia, EM | 1 |
| Mangubat, NV | 1 |
6 reviews available for prednisone and Chronic Hepatitis B
| Article | Year |
|---|---|
Immunoglobulin G4-associated de novo autoimmune hepatitis after liver transplantation for chronic hepatitis B- and C-related cirrhosis and hepatocellular carcinoma: a case report with literature review.
Topics: Antiviral Agents; Azathioprine; Carcinoma, Hepatocellular; Coinfection; Drug Therapy, Combination; H | 2013 |
Hepatitis reactivation in patients with rheumatic diseases after immunosuppressive therapy--a report of long-term follow-up of serial cases and literature review.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Arthritis, Rheumatoid; Azathioprine; Cohort Studies; Derm | 2014 |
[Hepatitis B reactivation in an HbsAg-negative/anti-HBc-positive patient with B-cell non-Hodgkin lymphoma receiving chemotherapy with rituximab].
Topics: Adenine; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antibody | 2010 |
Treatment of HBe antigen-positive chronic hepatitis B.
Topics: Alanine Transaminase; Anti-Inflammatory Agents; Antiviral Agents; Drug Resistance; Hepatitis B e Ant | 2003 |
Treatment of chronic viral hepatitis.
Topics: Antiviral Agents; Glucocorticoids; Hepacivirus; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C | 1999 |
[Hepatic MALT lymphoma disclosing a nodal extension].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Doxorubicin; Hepatitis B, | 2000 |
5 trials available for prednisone and Chronic Hepatitis B
| Article | Year |
|---|---|
Immunosuppressive treatment combined with nucleoside analog is superior to nucleoside analog only in the treatment of severe thrombocytopenia in patients with cirrhosis associated with hepatitis B in China: A multicenter, observational study.
Topics: Adult; Blood Coagulation Tests; China; Cyclosporine; Drug Therapy, Combination; Female; Hemorrhage; | 2015 |
Serological and molecular response on combined antiviral treatment in children with chronic hepatitis B after pediatric malignancy.
Topics: 2-Aminopurine; Adolescent; Antiviral Agents; Child; Child, Preschool; DNA, Viral; Drug Therapy, Comb | 2002 |
[Sequential combination therapy with prednisone, lamivudine and interferon alfa-2b for HBeAg-positive chronic hepatitis B].
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Glucocorticoids; Hepatitis B e Antigens; | 2006 |
Interferon-alpha2b therapy is efficacious in Asian-Americans with chronic hepatitis B infection: a prospective controlled trial.
Topics: Adult; Alanine Transaminase; Antiviral Agents; Asian; DNA, Viral; Hepatitis B e Antigens; Hepatitis | 1998 |
Randomized, double-blind, placebo-controlled trial of oromucosal low-dose interferon following prednisone withdrawal for chronic hepatitis B infection in Filipino patients.
Topics: Administration, Oral; Adult; Antiviral Agents; Double-Blind Method; Drug Administration Schedule; Fe | 2002 |
19 other studies available for prednisone and Chronic Hepatitis B
| Article | Year |
|---|---|
Average corticosteroid dose and risk for HBV reactivation and hepatitis flare in patients with resolved hepatitis B infection.
Topics: Adrenal Cortex Hormones; Antiviral Agents; Hepatitis A; Hepatitis B; Hepatitis B Antibodies; Hepatit | 2022 |
A Prospective Study of Preemptive Tenofovir Disoproxil Fumarate Therapy in HBsAg-Positive Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone.
Topics: Alanine Transaminase; Antiviral Agents; Cyclophosphamide; DNA, Viral; Doxorubicin; Hepatitis B Surfa | 2023 |
Treated chronic hepatitis B is a good prognostic factor of diffuse large B-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cyclophosphamide; Doxorubicin; Hep | 2023 |
Recurrent optic neuritis as the only manifestation of chronic hepatitis B virus flare: a case report.
Topics: Antiviral Agents; Glucocorticoids; Guanine; Hepatitis B, Chronic; Humans; Male; Middle Aged; Optic N | 2018 |
Management of refractory telaprevir-induced dermatitis using oral corticosteroids.
Topics: Administration, Oral; Aged; Anti-Inflammatory Agents; Antiviral Agents; Drug Eruptions; Drug Therapy | 2014 |
Reducing the risk of infection in a 74-year-old man who is to receive prednisone.
Topics: Aged; Glucocorticoids; Hepatitis B, Chronic; Humans; Lamivudine; Latent Tuberculosis; Male; Pemphigo | 2014 |
Static and dynamic prognostic factors for hepatitis-B-related acute-on-chronic liver failure.
Topics: Acute-On-Chronic Liver Failure; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic | 2015 |
Peripheral Ulcerative Keratitis Secondary to Chronic Hepatitis B Infection.
Topics: Antiviral Agents; Corneal Ulcer; Cryoglobulinemia; Cyclophosphamide; Female; Glucocorticoids; Hepati | 2017 |
Efficacy and Safety of Omalizumab in a Patient With Chronic Spontaneous Urticaria and Active Hepatitis B Virus Infection.
Topics: Anti-Allergic Agents; Benzimidazoles; Chronic Disease; Drug Therapy, Combination; Female; Hepatitis | 2017 |
Fatal reactivation of hepatitis B after chemotherapy for lymphoma.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemo | 2008 |
[Cutaneous presentation of plasmablastic lymphoma in a patient with HIV Infection].
Topics: Adult; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cyclophospha | 2008 |
Hepatic failure due to hepatitis B reactivation in a patient with ulcerative colitis treated with prednisone.
Topics: Adult; Colitis, Ulcerative; Glucocorticoids; Hepatitis B, Chronic; Humans; Liver Failure, Acute; Mal | 2009 |
Exacerbation of chronic idiopathic thrombocytopenic purpura following reactivation of an occult hepatitis B.
Topics: Adult; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic | 2010 |
[Icteric hepatitis in a patient with non-Hodgkin's lymphoma treated by rituximab-based chemotherapy].
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antiviral Ag | 2010 |
Sorafenib-induced destructive thyroiditis.
Topics: Antineoplastic Agents; Benzenesulfonates; Carcinoma, Hepatocellular; Chronic Disease; Hepatitis B, C | 2010 |
Acute liver failure related to chemotherapy.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclo | 2012 |
[Reactivation of hepatitis B after treatment with CHOP and rituximab].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplasti | 2007 |
[Current treatment of hepatitis B].
Topics: 2-Aminopurine; Adenine; Anti-Inflammatory Agents; Antiviral Agents; DNA Replication; Famciclovir; Fo | 2001 |
Prophylactic effect of interferon-alpha for exacerbation of hepatitis B after high-dose chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Cyclo | 2001 |